Abstract
Public health experts often describe care in India’s private sector as ‘chaotic,’ ‘substandard,’ ‘profit-driven,’ and ‘arbitrary.’ Discourse tends to focus on the ‘predatory behavior' of doctors who demand consultation fees and kickbacks for everything from medicine, to laboratory tests, to specialist referrals, and even hospital stays. These practices are ethnographically observable. However, this discourse does not take into account the multiple uncertainties, ethical complexity, and personal relationships involved in providing care in exchange for money in a setting of scarce personal and public resources. Situated at the very end of a value chain designed to make money from health, or the lack thereof, private physicians find themselves embroiled in moral peril. In this article, I engage what it means to make a livelihood in a context such as this by considering the economic, moral, and epistemic practices that physicians and their patients use to create and evaluate the value of pharmaceuticals in Mumbai’s slums. Based on over a year of clinic ethnography and interviews with family physicians, specialists, pharmacists, and pharmaceutical wholesalers, I trace how physicians manage the effects of a pharmaceutical value chain that produces profit by fulfilling patient’s health needs and desires.
Similar content being viewed by others
Notes
All names are pseudonyms. Forthwith, I use physicians’ first and last names on first mention. In subsequent mentions, I use either their first name or last name depending on the convention among their patients and themselves.
Most Mumbai and Delhi-based general physicians provide pharmaceuticals to patients as part of their fees. The law prohibits the sale of medicines by anyone but licensed pharmacists, so Dr. Zahir describes these pharmaceuticals as “gifts.”
Slum is a contested category in Mumbai. In general slum refers to an unplanned settlement but also expands to planned settlements characterized by a lack in services and disorganized settlement patterns, encroachments, and crowding (Bjorkman 2014).
Public health scholars describe the private medical sector as an aggregation of those medical services not located in a center run by local, state, or central government. Though these physicians are often accused of asking patients who visit their public sector practices to attend their private clinic, I saw only one instance of this action. On the contrary I observed several instances of these physicians referring patients from their private clinics to their public sector practices.
Bachelor of Ayurveda, Medicine and Surgery, Bachelor of Homeopathy, Medicine and Surgery, and Bachelor of Unani, Medicine and Surgery are all government recognized degrees in alternative medicine. Though trained in alternative systems these practitioners in Mumbai commonly practice a combination of alternative and biomedicine or biomedicine exclusively (McDowell and Pai 2016a, b). They make up the majority of physicians in the city’s 12 high burden wards.
Jhola Chhap, Hindi for “satchel mark” doctors, are named after their once itinerant lifestyle and clinic-in-a bag treatment paradigm. This is a common Hindi moniker for those practicing as physicians without formalized training in any system. Pinto calls them “ersatz” (2004) while Das calls them Bengali doctors (2015). I have written of them elsewhere as Bengali doctors (McDowell 2017).
India is a global leader of pharmaceutical production, and factories producing generic drugs are common in Western India, as well as Himanchal Pradesh. ‘Local quality’ drugs, which physicians buy in bulk, are often produced in the slums of Mumbai in cottage industries and sold in plastic bags. Ahmedabad and Surat are also hubs of production.
I present all quotations in my own translation. Though I understand Marathi well and can speak it when necessary, I have asked native speakers to double check any translations from Marathi provided here.
This makes the two slums nearly five times more densely populated than Manhattan and 16 times more densely populated than Paris.
All person and place names have been changed. A diversity of names has been used to reflect the diversity of actors involved.
Rantac is a trade name for ranitidine a drug used for heartburn and indigestion sold in the US as Zantac®.
Marathi for “What’s the problem?” “Do you have fever?”.
Dexamethasone is a commonly used steroid.
Available on youtube: https://www.youtube.com/watch?v=1Lg0kUtS8ic.
References
Achanta, S., J. Jaju, A.M. Kumar, S.B. Nagaraja, S.R.M. Shamrao, S.K. Bandi, A. Kumar, S. Satyanarayana, A.D. Harries, and S.A. Nair. 2013. Tuberculosis management practices by private practitioners in Andhra Pradesh, India. PLoS ONE 8 (8): e71119.
Appadurai, A. 1986. Introduction: commodities and the politics of value. In The social life of things: Commodities in cultural perspective, ed. A. Appadurai, 3–63. Cambridge: Cambridge University Press.
Bhargava, A., L. Pinto, and M. Pai. 2011. Mismanagement of tuberculosis in India: Causes, consequences, and the way forward. Hypothesis 9 (1): 1–8.
Bhat, R. 1999. Characteristics of private medical practice in India: a provider perspective. Health Policy and Planning 14 (1): 26–37.
Björkman, L. 2014. Becoming a slum: From municipal colony to illegal settlement in liberalization-era Mumbai. International Journal of Urban and Regional Research 38 (1): 36–59.
Brhlikova, P., I. Harper, R. Jeffery, N. Rawal, M. Subedi, and M. Santhosh. 2011. Trust and the regulation of pharmaceuticals: South Asia in a globalised world. Globalization and Health 7 (1): 1.
Chorev, N. 2020. Give and take: Developmental foreign aid and the pharmaceutical industry in East Africa. Princeton studies in global and comparative sociology. Princeton: Princeton University Press.
Cross, J., and H.N. MacGregor. 2010. Knowledge, legitimacy and economic practice in informal markets for medicine: A critical review of research. Social Science & Medicine 71 (9): 1593–1600.
Darby, M., and E. Karni. 1973. Free competition and the optimal amount of fraud. Economics 16 (1): 67–88.
Das, J., and J. Hammer. 2007a. Location, location, location: residence, wealth, and the quality of medical care in Delhi, India. Health Affairs 26 (3): w338–w351.
Das, J., and J. Hammer. 2007b. Money for nothing: The dire straits of medical practice in Delhi, India. Journal of Development Economics 83 (1): 1–36.
Das, J., A. Kwan, B. Daniels, S. Satyanarayana, R. Subbaraman, S. Bergkvist, R.K. Das, V. Das, and M. Pai. 2015. Use of standardised patients to assess quality of tuberculosis care: A pilot, cross-sectional study. The Lancet Infectious Diseases 15 (11): 1305–1313.
Das, V. 2015. Afflication: Health, disease, poverty. New York: Fordham University Press.
Das, V., and R.K. Das. 2006. Pharmaceuticals in urban ecologies: The register of the local. In Global pharmaceuticals: Ethics, markets, practices, ed. A. Petryna, A. Lakoff, and A. Kleinman. Durham: Duke University Press.
Daviron, B.T., and S. Ponte. 2005. The coffee paradox: Global markets, commodity trade, and the elusive promise of development. New York: Zed Books.
De Costa, A., and V. Diwan. 2007. ‘Where is the public health sector?’: Public and private sector healthcare provision in Madhya Pradesh, India. Health Policy 84 (2): 269–276.
De Costa, A., E. Johansson, and V.K. Diwan. 2008. Barriers of mistrust: Public and private health sectors’ perceptions of each other in Madhya Pradesh, India. Qualitative Health Research 18 (6): 756–766.
Deshpande, K., V. Diwan, K. Lönnroth, V.K. Mahadik, and R.K. Chandorkar. 2004. Spatial pattern of private health care provision in Ujjain, India: A provider survey processed and analysed with a Geographical Information System. Health Policy 68 (2): 211–222.
Duggal, R. 2012. The uncharitable trust hospitals. Economic and Political Weekly 47 (25): 23–24.
Dumit, J. 2012. Drugs for life how pharmaceutical companies define our health. Experimental futures. urham, N.C.: Duke University Press.
Ecks, S. 2013. Eating drugs: Psychopharmaceutical pluralism in India. New York: NYU Press.
Ecks, S. and I. Harper. 2013. Public-private mixes: the market for anti-tuberculosis drugs in India. When people come first: Critical studies in global health, pp. 252–275.
Eiss, P.K., and D. Pedersen. 2008. Introduction: Values of value. Cultural Anthropology 17 (3): 283–290.
Elyanchar, J. 2012. Before (and after) neoliberalism: Tacit knowledge, secrets of the trade, and the public sector. Cultural Anthropology 27: 76–96.
Esquerre, A., and L. Boltanski. 2017. Enrichissement: Une critique de la marchandise. Paris: Gallimard.
Fainzang, S. 1997. Les stratégies paradoxales. Réflexions sur la question de l’incohérence des conduites des malades. Sciences sociales et santé 15 (3): 5–23.
Fainzang, S. 2002. Lying, secrecy and power within the doctor–patient relationship. Anthropology & Medicine 9 (2): 117–133.
Fainzang, S. 2016. An anthropology of lying: Information in the doctor–patient relationship. London: Routledge.
Fochsen, G., K. Deshpande, and A. Thorson. 2006. Power imbalance and consumerism in the doctor–patient relationship: Health care providers’ experiences of patient encounters in a rural district in India. Qualitative Health Research 16 (9): 1236–1251.
Foucault, M. 1966. Les mots et les choses: une archéologie des sciences humaines: une archéologie des sciences humaines. New York: Gallimard.
Foucault, M. 1973. The birth of the clinic. New York: Parthenon.
Garau, P., E.D. Sclar, and G.Y. Carolini. 2005. A home in the city: Achieving the Millenium Development Goals. London: Earthscan.
Geest, S.V.D., and S.R. Whyte. 1988. The Context of medicines in developing countries: Studies in pharmaceutical anthropology. Culture, illness, and healing. Dordrecht: Kluwer Academic.
George, A., and A. Iyer. 2013. Unfree markets: Socially embedded informal health providers in northern Karnataka, India. Social Science & Medicine 96: 297–304.
Graeber, D. 2001. Toward an anthropological theory of value: The false coin of our own dreams. New York: Palgrave.
Guérin, I. 2014. Juggling with debt, social ties, and values: The everday use of microcredit of microcredit in rural South India. Current Anthropology 55: S40–S50.
Guyer, J.I. 2004. Marginal gains: Monetary transactions in Atlantic Africa. The Lewis Henry Morgan lectures Chicago: University of Chicago Press.
Hayden, C. 2003. When nature goes public: The making and unmaking of bioprospecting in Mexico. Princeton: Princeton University Press.
Health, W. C. o. S. D. o. 2008. Our cities, our helath, our future: Acting on social determinants for health equity in urban settings. Kobe: WHO Centre for Helath Development.
Herzfeld, M. 2005. Political optics and the occlusion of intimate knowledge. American Anthropologist 107 (3): 369–376.
Herzfeld, M. 2014. Cultural intimacy: Social poetics in the nation-state. London: Routledge.
Janzen, J.M., and W. Arkinstall. 1978. The quest for therapy in Lower Zaire. Comparative studies of health systems and medical care. Berkeley: University of California Press.
Kamat, V.R. 2001. Private practitioners and their role in the resurgence of malaria in Mumbai (Bombay) and Navi Mumbai (New Bombay), India: serving the affected or aiding an epidemic? Social Science & Medicine 52 (6): 885–909.
Kamat, V.R., and M. Nichter. 1998. Pharmacies, self-medication and pharmaceutical marketing in Bombay, India. Social Science & Medicine 47 (6): 779–794.
Kapoor, S.K., A.V. Raman, K.S. Sachdeva, and S. Satyanarayana. 2012. How did the TB patients reach DOTS services in Delhi? A study of patient treatment seeking behavior. PLoS ONE 7 (8): e42458.
Khare, R. 1996. Dava, Daktar, and Dua: Anthropology of practiced medicine in India. Social Science & Medicine 43 (5): 837–848.
Kleinman, A. 1999. Experience and its moral modes: Culture, human conditions, and disorder. Tanner Lectures on Human Values 20: 355–420.
Lambek, M. 2001. The value of coins in a Sakalava polity: money, death, and historicity in Mahajanga, Madagascar. Comparative Studies in Society and History 43 (4): 735–762.
Lambek, M. 2008. Value and virtue. Anthropological Theory 8 (2): 133–157.
Lönnroth, K., M. Uplekar, V.K. Arora, S. Juvekar, N.T. Lan, D. Mwaniki, and V. Pathania. 2004. Public-private mix for DOTS implementation: What makes it work? Bulletin of the World Health Organization 82 (8): 580–586.
Mackintosh, M., A. Channon, A. Karan, S. Selvaraj, E. Cavagnero, and H. Zhao. 2016. What is the private sector? Understanding private provision in the health systems of low-income and middle-income countries. The Lancet 388 (10044): 596–605.
Malinowski, B. 1961. Argonauts of the western Pacific: An account of native enterprise and adventure in the Archipelagoes of Melanisian New Guinea. New York: Dutton.
Martin, E. 2006. The pharmaceitucal person. Biosocieties 1 (3): 273–287.
Marx, K., and F. Engels. 1967. Capital, a critique of political economy. New World paperbacks. New York: International Publishers.
Mauss, M. 1990. The gift: The form and reason for exchange in archaic societies. London: Routledge.
McDowell, A. 2017. Mohit’s Pharmakon: Symptom, rotational bodies and phramaceuticals in rural Rajasthan. Medical Anthropology Quarterly 31 (3): 332–348.
McDowell, A., and M. Pai. 2016a. Alternative medicine: An ethnographic study of how practitioners of Indian medical systems manage TB in Mumbai. Transactions of The Royal Society of Tropical Medicine and Hygiene 110 (3): 192–198.
McDowell, A., and M. Pai. 2016b. Treatment as diagnosis and diagnosis as treatment: Empirical management of presumptive TB in the Indian private sector. International Journal of Tuberculosis and Lung Disease 20 (4): 536–543.
Meier zu Biesen, C. 2018. From costal to global: The transnational flow of Ayurveda and its relevance for Indo-African linkages. Global Public Health 13 (3): 339–354.
Mistry, N., S. Rangan, Y. Dholakia, E. Lobo, S. Shah, and A. Patil. 2016. Durations and delays in care seeking, diagnosis and treatment initiation in uncomplicated pulmonary tuberculosis patients in Mumbai, India. PLoS ONE 11 (3): e0152287.
Munn, N.D. 1992. The fame of Gawa: A symbolic study of value transformation in a Massim (Papua New Guinea) society. Durham: Duke University Press.
Nandraj, S. 2015. Unregulated and unaccountable: Private health providers. Economic and Political Weekly 47 (4): 12.
Narotzky, S., and N. Besnier. 2014. Crisis, value, and hope: Rethinking the economy. Current Anthropology 55 (S9): S4–S16.
Nelson, P. 1970. Information and consumer behavior. Journal of Political Economy 78 (2): 311–329.
Parry, J. 1989. On the moral perils of exchange. In Money and the morality of exchange, ed. J. Parry and M. Bloch, 64–93. Cambridge: Cambridge University Press.
Paxson, H. 2010. Locating value in artisan cheese: Reverse engineering terroir in New-World Landscapes. American Anthropologist 112 (3): 444–457.
Peterson, K. 2014. Speculative markets: drug circuits and derivative life in Nigeria. Experimental futures: Technological lives, scientific arts, anthropological voices. Durham: Duke University Press.
Petryna, A. 2009. When experiments travel: Clinical trials and the global search for human subjects. Princeton: Princeton University Press.
Petryna, A., A. Lakoff, and A. Kleinman. 2006. Global pharmaceuticals: Ethics, markets, practices. Durkham: Duke University Press.
Pinto, S. 2004. Development without institutions: Ersatz medicine and the politics of everyday life in rural north India. Cultural Anthropology 19 (3): 337–364.
Polanyi, K. 1944. The great transformation. New York: Farrar & Rinehart.
Pordié, L., and J.-P. Gaudilière. 2014. The reformulation regime in drug discovery: Revisiting polyherbals and property rightsin the ayurvedic industry. East Asian Science, Technology and Society 8 (1): 57–79.
Quet, M. 2018. Impostures pharmaceutiques: Médicaments illicites et luttes pour l’accès à la santé. Paris: Éditions La Découverte.
Rajan, K.S. 2003. Genomic capital: Public cultures and market logics of corporate biotechnology. Science as Culture 12 (1): 87–121.
Ramberg, L. 2014. Given to the goddes: South Indian devadasis and the sexuality of religion. Durham: Duke University Press.
Satyanarayana, S., A. Kwan, B. Daniels, R. Subbaraman, A. McDowell, S. Bergkvist, R.K. Das, V. Das, J. Das, and M. Pai. 2016. Use of standardised patients to assess antibiotic dispensing for tuberculosis by pharmacies in urban India: A cross-sectional study. The Lancet Infectious Diseases 16 (11): 1261–1268.
Seeberg, J. 2012. Connecting pills and people. Medical Anthropology Quarterly 26 (2): 182–200.
Sreeramareddy, C.T., Z.Z. Qin, S. Satyanarayana, R. Subbaraman, and M. Pai. 2014. Delays in diagnosis and treatment of pulmonary tuberculosis in India: A systematic review. The International Journal of Tuberculosis and Lung Disease 18 (3): 255–266.
Srinivas, T. 2016. The cow in the elevator: An anthropology of wonder. Durham: Duke University Press.
Sunder Rajan, K. 2006. Biocapital: The constitution of postgenomic life. Durham: Duke University Press.
Sunder Rajan, K. 2017. Pharmocracy value, politics & knowledge in global biomedicine. Durham: Duke University Press.
Thompson, E.P. 1966. The making of the English working class. New York: Vintage Books.
Udwadia, Z.F., L.M. Pinto, and M.W. Uplekar. 2010. Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades? PLoS ONE 5 (8): e12023.
Varman, R., and R.M. Vikas. 2007. Rising markets and failing health: An inquiry into subaltern health care consumption under neoliberalism. Journal of Macromarketing 27 (2): 162–172.
Walsh, A. 2012. Made in Madagascar: Sapphires, ecotourism, and the global bazaar. Toronto: University of Toronto Press.
Weber, M. 1930. The Protestant ethic and the spirit of capitalism. New York: Scribner.
Whyte, S.R., and S. Geest. 2002. The social life of medicines. Cambridge: Cambridge University Press.
Yesudian, C. 1994. Behaviour of the private sector in the health market of Bombay. Health Policy and Planning 9 (1): 72–80.
Acknowledgements
I owe debts of gratitude to innumerable Mumbaikars who by sharing informal chats in waiting rooms, at bus stops, and across pharmacy counters helped me learn more about medicine. I am deeply indebted to Prashant Kumbhar and M. Afzal Sheikh for introductions to their neighborhoods and the great kindness shown to me by physicians, pharmacists and all other kinds of medical practitioners. Without their insights and engagement, the paper would not have been possible. I am also grateful for Shibhu Vijayan, Ravdeep Gandhi, Rishabh Chopra, Jalpa Thakkar, K. Praveen, Vaishnavi Jondhale, Nilesh Dhotre, Varsha Nagwekar, Vaibhav Saria, Nambi Konar, Eunice Lobo, and Vrushal Walkar’s shared fieldwork and friendship. Puneet Diwan, Daksha Shah, Arun Bamne, Nerges Mistry, Madhukar Pai, Ursula Rao, Maya Unnithan, Sarah Pinto, and Jean-Paul Gaudilliere asked challenging questions of earlier iterations of this work and certainly made it stronger. Veena Das shaped this project. Without her subtle tending, it may never have grown. Adeline Masquelier, Allison Truitt, and Tara Dankel provided crucial eleventh-hour insights that helped zero in on value. Finally, I am indebted to the Foundation for Medical Research, Mumbai and Nerges Mistry for innumerable forms of support in Mumbai. Shortcomings are mine alone.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
McDowell, A. Dr. Zahir’s dilemma: money and morals in India’s private medical networks. BioSocieties 16, 363–386 (2021). https://doi.org/10.1057/s41292-020-00216-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1057/s41292-020-00216-2